Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pinto, L.M. Masfarre
6  Ergebnisse:
Personensuche X
?
1

242P Cyclin-dependent kinases inhibitors and dermatological..:

Pinto, L.M. Masfarre ; Pesque, D. ; Amorelli, F....
ESMO Open.  8 (2023)  1 - p. 101430 , 2023
Link: https://doi.org/10.1016/..
 
?
2

55P Differences in response to immune treatment between KRA..:

Pinto, L. Masfarre ; De Freitas Matos-Parreira, A.S. ; Unanua, N. Castro...
ESMO Open.  9 (2024)  - p. 102634 , 2024
Link: https://doi.org/10.1016/..
 
?
3

193P Differences in response to immunotherapy between KRAS ..:

Pinto, L. Masfarre ; Rocha, P. ; Clave, S....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S145-S146 , 2023
Link: https://doi.org/10.1016/..
 
?
4

165P SCLC subtypes are associated with distinct dinicopatho..:

Rocha, P. ; Sanchez, I. ; Pinto, L. Masfarre...
Journal of Thoracic Oncology.  18 (2023)  4 - p. S131 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Impact of Lymphopenia on Treatment Outcomes in Unresectable..:

Amorelli, F. ; Martinez, A. ; Liu, F....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. e2-e3 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EP14.05-002 Impact of Body Mass Index on Survival in Patien..:

Rios-Hoyo, A. ; Masfarré, L. ; Navarro-Gorro, N....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S543-S544 , 2022
Link: https://doi.org/10.1016/..
 
1-6